Loading clinical trials...
Loading clinical trials...
The purpose of this study is to develop an integrated view of molecular mechanisms underlying CF lung disease severity.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis
NCT04530383 · Cystic Fibrosis-related Diabetes, Cystic Fibrosis
NCT06154447 · Cystic Fibrosis
NCT05722340 · Lung Diseases, Interstitial
NCT05422222 · Cystic Fibrosis
Johns Hopkins University
Baltimore, Maryland
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Case Western Reserve University
Cleveland, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions